Biospherics Inc.

BY THE NUMBERS

May 06, 1992

This Greenbelt-based biotechnology company reported growth in revenues and profits for the first quarter, in large part because of a strong performance by the company's Information Services Division.

The company said its Environmental and Laboratory Services Division reduced its loss, despite lower revenues, by instituting cost-cutting measures.

Also during the first quarter, Pfizer Inc. purchased the right to negotiate with Biospherics for the commercialization of D-tagatose, Biospherics' patented, non-fattening sugar. Pfizer is continuing to study that option.

Three months ended 3/31/92

... ... ..Revenue... .... .... Net. ... . Share

'92 . ..3,799,815.. .. ... 110,898..... 0.03

'91 .. .3,509,093. ... ... (173,054)... (0.04)

% change . +8.3... .... .. ... --.. .. . .. --

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.